CorMedix Inc. (CRMD)
CorMedix Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
CorMedix Inc. (CRMD) is a Biotechnology company based in US with a market capitalization of $642.5M. The company generated $172.8M in free cash flow. This page tracks CRMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 64 employees · IPO May 13, 2010
Valuation
Valuation & price
$7.55as of May 17, 2026· -49.1% vs 52w high
3.7
P/E ratio
Latest-FY diluted EPS
1.59
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$642.5M
Market cap
—
Revenue growth (YoY)
88.5%
Gross margin
$172.8M
Free cash flow (USD)
-$605K
Net debt
Net cash position
22.4%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 14, 2026 (EPS $0.43)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 2, 2026Filing
Executive Leadership Change
- 8-K eventJul 1, 2026Filing
Accounting Firm Change
- 8-K eventJun 24, 2026Filing
Annual Meeting Results
- 8-K eventJun 8, 2026Filing
Patent Litigation Outcome
- 8-K eventMay 14, 2026Filing
Earnings Release
- Quarterly reportMay 14, 2026Filing
10-Q Filed
- 8-K eventApr 27, 2026Filing
Phase III Study Results
Questions
Frequently asked questions
What is CorMedix Inc.'s market cap?
CorMedix Inc. (CRMD) has a market capitalization of $642.5M.
What is CRMD's P/E ratio?
CRMD trades at a price-to-earnings ratio of 3.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is CRMD's price-to-book (P/B) ratio?
CRMD trades at 1.59 times book value per share.
When did CorMedix Inc. last report earnings?
CRMD last reported earnings on May 14, 2026; the next date is not yet scheduled.
Are insiders buying CRMD stock?
SEC Form 4 filings show no open-market insider buys at CorMedix Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.